Filing Details
- Accession Number:
- 0001209191-21-070839
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-21 18:33:13
- Reporting Period:
- 2021-12-17
- Accepted Time:
- 2021-12-21 18:33:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1324991 | L James Tyree | C/O Chemocentryx, Inc. 835 Industrial Road, Suite 600 San Carlos CA 94070 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-17 | 25,000 | $12.62 | 40,275 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-12-17 | 12,500 | $14.42 | 52,775 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-12-17 | 2,800 | $33.52 | 49,975 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-17 | 16,634 | $34.74 | 33,341 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-17 | 18,066 | $35.50 | 15,275 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-12-17 | 25,000 | $0.00 | 25,000 | $12.62 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-12-17 | 12,500 | $0.00 | 12,500 | $14.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-06-05 | No | 4 | M | Direct | |
| 0 | 2022-06-22 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $33.14 to $34.09 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $34.15 to $35.14 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $35.15 to $35.90 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- As of December 17, 2021, and prior to this transaction, the exercised options were fully vested.
- Not applicable.
Billionaire Hedge Funds
